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Background/aim: We aimed to compare the success rate of percutaneous nephrostomy (PCN) and double J stenting (DJS) in the
treatment of symptomatic pregnancy hydronephrosis.
Materials and methods: Diagnosis and grading of hydronephrosis were performed by urinary ultrasound (USG) and Doppler mode
was used for evaluation of renal arterial resistivity index (RI). Patients were divided into two groups according to the method used for
the treatment of hydronephrosis: group A (PCN, n = 38) and group B (DJS, n = 46). A P value < 0.05 was considered significant.
Results: The number of patients requiring second intervention was higher in group B (P = 0.0018) and time to secondary intervention
was significantly earlier in group B also (P = 0.0025). The number of tertiary intervention was again higher in group B (5/16 vs. 1/6)
and the need for tertiary intervention was higher in patients who underwent DJS implantation as a secondary intervention than those
who underwent PCN (5/11 vs. 1/11, P = 0.0012). The time to tertiary intervention was longer in patients with PCN than in those with
DJS (P = 0.0048).
Conclusion: PCN may be preferred to DJS in symptomatic pregnancy hydronephrosis because it requires fewer re-interventions after
longer times.
Key words: Percutaneous nephrostomy, hydronephrosis, ureteral catheters, pregnancy

1. Introduction
Pregnancy is a process causing significant anatomical and
physiological changes in all organ systems. The urinary
system is among the systems exposed to these changes
during pregnancy and hydroureteronephrosis is the most
significant of them. An average increase of 50%–70% in
renal blood flow and 30%–50% increase in glomerular
filtration rate occur during pregnancy. Intense exposure to
progesterone induces decreased peristaltism in the ureter
smooth muscle and dilating of the ureters. Typically,
hydronephrosis begins at 6 to 10 weeks of gestation and
occurs in 90% of pregnant women in the last trimester
(1). Hydronephrosis that occurs in the early stages of
pregnancy is associated with increased progesterone. In
later stages of the pregnancy, the ureteral pressure of the
growing uterus and physiological dilation of the right
ovarian vein are the main reasons for hydronephrosis (2).
This pressure effect is monitored on the right side 2–3
times more than on the left side (3). On the left side, the
existence of the sigmoid colon prevents the compression
of the ureter (4). These changes in ureters usually resolve
within 4–6 weeks after birth.
* Correspondence: fuatkizilay@gmail.com

The most common nonobstetric indication for
hospitalization during pregnancy is abdominal or flank
pain (5). It is fundamental for the clinician to determine
whether the pain is originating from the urinary system,
to distinguish between physiologic and pathological
dilation if the pain is originating from the urinary system,
and finally to determine the most appropriate treatment
method if the dilation is pathological. Conservative
treatment methods are primarily preferred in pregnancy
hydronephrosis unless invasive methods are mandatory.
If there is no amelioration of symptoms despite a
conservative approach, interventional treatments such as
ureteral catheterization and percutaneous nephrostomy
(PCN) may be required. Both PCN and double J stenting
(DJS) are widely used methods to alleviate hydronephrosis
in pregnancy (6,7). Symptomatic hydronephrosis is a
urological emergency as it may cause premature labor
and should be alleviated as quickly as possible. In this
retrospective study, we aimed to compare the PCN and
DJS outcomes in our pregnant patients who did not
respond to conservative treatment and had symptomatic
hydronephrosis. To the best of our knowledge, this is the
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first study comparing these two methods in the treatment
of pregnancy hydronephrosis.
2. Materials and methods
This retrospective study was conducted in the urology
clinic of a third step university hospital. The data of
pregnant patients who underwent PCN and DJS between
January 2000 and December 2016 were collected from the
patient files. The study was conducted in compliance with
the Declaration of Helsinki.
2.1. Patient selection
A total of 84 patients were included in the study. Urinary
ultrasonography (USG) was performed for diagnosis and
grading of hydronephrosis; renal USG was performed in
Doppler mode for assessment of renal arterial resistivity
index (RI). The hydronephrosis grading was done according
to the grading system of the Society of Fetal Ultrasound
(SFU) and the renal arterial RI was calculated using the
“peak systolic velocity – end diastolic velocity / peak
systolic velocity” formula. Urinary USG was performed
by different physicians, but a physician experienced in
urological radiology supervised all applications. Patients
were divided into two groups according to the method
used for the treatment of hydronephrosis: group A (PCN,
n = 38) and group B (DJS, n = 46). Only patients who were
thought to have hydronephrosis due to pregnancy were
included in the study. A total of 14 patients with ureteral
stones (n = 6), ureteropelvic junction stenosis (n = 4),
and ureteropelvic junction stones (n = 4) were excluded
from the study. The PCN or DJS was implanted according
to the preference of the patients. In those without a
preference, the intervention was performed according to
the preference of both the surgeon and the patients. If the
patient did not have a preference about the intervention
method, a decision was made based on some predictive
factors. PCN application is preferred if hydronephrosis
grade is high in USG, echogenic particles appear pointing
to infected urine, patient is at high risk for anesthesia, and
the patient is in early gestational weeks. However, if these
findings are not present, DJS is preferred, especially if the
patient is in the third trimester and the risk of anesthesia is
not high. Data of the patients were analyzed according to
the applied methods in terms of success of hydronephrosis
relief and the necessity and time of re-interventions.
2.2. Operation and intervention techniques
DJS implementation was performed under general
anesthesia. Informed, written consent was obtained before
the procedure. The patients consulted with the gynecology
clinic prior to the operation and their approval was
received for the operation. Sterile urine was provided by
all patients before the surgery. One gram of cefazolin was
administered intravenously with anesthesia induction.
In lithotomy position, a 22 Fr endoscope (Karl Storz,
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Germany) was introduced into the urethral meatus. After
the ureteral orifice was visualized, a 6 Fr open-ended
ureter catheter was gently passed 1–2 cm through the
ureterovesical orifice. A sensor PTFE-Nitinol Guidewire
(Boston Scientific) was passed through the open-ended
catheter. After being sure that the sensor was in the renal
collecting system with a single shot of the fluoroscopy, a
6 Fr DJS (26 cm, 0.035”, silicone based, Elit Medikal) was
placed in the collecting system by sliding over the sensor.
PCN implementations were also performed by the
urology clinic. Informed, written consent of the patients
was obtained before the procedure. Patients were
repositioned on the opposite side of the kidney to receive
the intervention. The intervention planned access tract
and the calyx were determined with USG. Five milligrams
of lidocaine was injected into the access tract. After 10
min, the access was performed with a nephrostomy needle
into the planned calyx with the guidance of USG. A
guide-wire was passed from the needle into the collecting
system and after dilation of the tract with serial dilators a
8 Fr nephrostomy tube (Boston Scientific) was implanted.
After the urine output was seen through the tube, it was
fixed to the skin with 2/0 silk sutures.
2.3. Data collection
The demographic data of patients, gestational week, and
intervention method were collected from patient files.
Hydronephrosis status in control USG, recurrence rate,
and number of re-intervention methods were recorded.
2.4. Outcome measures
Our primary outcome measures were postintervention
hydronephrosis status and recurrence rate and number.
The secondary outcome was the comparison of the rate
and number of recurrences and the success rate of the two
methods in relieving hydronephrosis between the groups.
2.5. Statistical analysis
The normal distribution of the data was checked by
Kolmogorov–Smirnov test. Pearson’s correlation analysis
and Spearman rank and Mann–Whitney U-tests were used
for analysis of the variables. A two-tailed P value less than
0.05 was considered statistically significant. Multivariate
analysis was performed for the variables with statistically
significant results in the correlation analysis. All analyses
were performed using SPSS 23.0 for Macintosh.
3. Results
Over the last 16 years, a total of 84 pregnant patients
required intervention for symptomatic hydronephrosis
in our clinic. PCN was performed in 38 patients (group
A) and DJS was performed in 46 patients (group B).
Demographic data and gestational weeks of the patients
were similar between the two groups as shown in Table 1.
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Table 1. Demographic and gestation data of the patients.
Variablesa

PCNb group

DJSc group

P value

Number of cases

38

46

Age

24 (18–39)

22 (19–37)

0.580

Body mass index (kg/m2)

22.4 (17.8–32.1)

24.6 (18.2–33.5)

0.773

Parity

1.28 (1–4)

1.56 (1–3)

0.285

Gestational week at the time of intervention

26.4 (18.3–32.6)

27.8 (17.9–31.5)

0.801

Hydronephrosis grade

3.20 (1–4)

3.05 (1–4)

0.568

Renal arterial resistivity index

0.68 (0.61–0.83)

0.64 (0.58–0.81)

0.455

Values are given as mean (range) or number
Percutaneous nephrostomy
c
Double J stent
a

b

A total of 22 patients required a second intervention.
Six of them were in group A and 16 were in group B. The
second intervention was required 33 days after the first
procedure in the first group and 18 days in the second
group, respectively. PCN and DJS were implemented in
three patients each in the first group and eight patients each
in the second group. A third intervention was required
after 10 days in one of the 3 DJS-implanted patients in the
first group, after 16 days in one of the 8 PCN-implanted
patients, and after 8 days in the fourth of 8 DJS patients in
the second group. The third intervention was necessary in
a total of 6 patients. The reasons for the third intervention
were dislocation of the stent caudally in 2, increase in the
grade of hydronephrosis associated with encrustation in
1, and duration of the periodic replacement in 2 of 11
patients with DJS. The third intervention was required in
1 of 8 patients with PCN due to dislocation of the tube.
Thirty-one patients in the first group and 25 patients in the
second group did not require re-intervention. The study
flow diagram is shown in the Figure.
There was a significant difference between the
groups in terms of the need for secondary intervention
(15.7% vs. 34.7%, P = 0.0018). The time to secondary
intervention was significantly shorter in the DJS group
than in the PCN group (18 vs. 33 days, P = 0.0025). The
reasons for the secondary intervention were the increased
hydronephrosis grades and pain of the patients depending
on the dislocation or encrustation of the PCN or DJS. In
group A, 4 patients had an increase in hydronephrosis
grade despite the nephrostomy tube and the tube
dislocated in 2 patients. In group B, 6 patients had an
increase in hydronephrosis grade due to DJS encrustation,
6 patients had DJS dislocations, and 4 patients needed stent
replacement due to febrile urinary tract infection. In the
second group, the number of patients requiring tertiary

intervention was higher than in the first group (5/16 vs.
1/6) and the need for tertiary intervention was higher in
patients who underwent DJS implantation as a secondary
intervention than in those who underwent PCN (5/11 vs.
1/11, P = 0.0012). The time to tertiary intervention was
10 days in the DJS group in the first group, and 16 days in
the PCN group and 8 days in the DJS group in the second
group (P = 0.0048). Table 2 shows re-intervention rate,
type, and time.
4. Discussion
While asymptomatic hydronephrosis is seen in 90%
of pregnancies (8,9), the incidence of symptomatic
hydronephrosis in the literature varies by 0.2%–3% (10).
If symptomatic hydronephrosis is left untreated, it may
cause premature labor and maternal or fetal death (11).
Therefore, it is very important to distinguish symptomatic
hydronephrosis in pregnancy and to provide appropriate
treatment. Approximately 70%–80% of patients with
symptomatic hydronephrosis are treated conservatively,
while the remaining 20%–30% require invasive treatments
(11). Some predictive factors anticipating the success of the
intervention are also important in the choice of invasive
procedures, besides patient and physician preference. As
noted above, hydronephrosis grade, gestational week,
risk of anesthesia and comorbidities of the patient, urine
appearance in the USG image, and other associated
pathologies of the urinary tract are the main factors. On
the other hand, the European Association of Urology
guidelines suggest that PCN and DJS, two methods used
for emergency treatment of hydronephrosis, are equally
effective (12,13). These two methods are also frequently
used in pregnancy. However, a study comparing the
results of these two methods in pregnancy has not been
conducted yet.
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84 pregnant patients

367
368

38 underwent PCNa

46 underwent DJSb

33 days
3 patients (PCN)
(None required third
intervention)

18 day

3 patients (DJS)

8 patients (PCN)

10 days
1 patient (PCN)
384

392
31 patients
393

a
b

16 days
1 patient (PCN)

25 patients

375
8 patients (DJS)
376

Secondary
intervention

8 days
4 patients (PCN)

Tertiary
intervention

Re-intervention was not necessary

Percutaneous nephrostomy
Double J stent

Figure. Study flow diagram.

Due to high exposure to the hormone progesterone
in pregnancy, ureter peristaltism decreases and the ureter
becomes dilated. Therefore, it may be easier to perform
ureteroscopy in pregnancy and to indwell a stent (14).
However, severely disturbing symptoms such as dysuria,
flank and suprapubic pain, and urgency may occur due
to the stent. Ringel et al. reported that 32% of stents had
to be removed before the scheduled time due to their side
effects (15). With the developing technology, devices used
in urology have also been improved; thinner and flexible
ureteroscopes, laser lithotriptors, and new design basket
forceps have been developed. With these devices and safe
anesthesia methods stone treatment in pregnancy has
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been performed more conveniently in recent years (16).
Tsai et al. analyzed conservative and surgical management
for symptomatic moderate and severe hydronephrosis in
pregnancy. Fifty patients were included in the study; 25
of them were followed conservatively and 25 underwent
DJS implantation. The DJS group showed a lower failure
rate than the group receiving conservative treatment (P =
0.018) but 16% of patients had stent-related discomfort and
flank pain. They concluded that conservative treatment
should be the first option because of the discomfort
caused by surgical treatment although DJS is an effective
treatment modality for moderate to severe symptomatic
hydronephrosis (17).
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Table 2. Data of the patients in terms of re-intervention rate, type, and time.
Variablesa

PCNb group

DJSc group

Number of cases

38

46

Secondary intervention

6 / 15.7%

16 / 34.7%

0.0018

Secondary intervention time (day)

33

18

0.0025

Secondary intervention method

PCN

DJS

PCN

DJS

Number of cases

3

3

8

8

Tertiary intervention

None

1 / 33.3%

1 / 12.5%

4 / 50.0%

0.0012

10

16

8

0.0048

Tertiary intervention time (day)

P value

Values are given as number or percentage
Percutaneous nephrostomy
c
Double J stent
a

b

The risk of stent calcification is high because of
changes in electrolyte balance in pregnancy. Goldfarb et
al. presented a case of accelerated incrustation due to the
hypercalciuric situation in pregnancy and emphasized
the need for hydration, calcium restriction, and close
monitoring to prevent infection and stone formation
in pregnancy (18). Peer et al. have pointed out the risk
of technical difficulties of stent application, anesthesia
requirement, and inducing birth, and reported that
pain and pyonephrosis were successfully treated with
percutaneous nephrostomy in their patients and pregnancy
continued uneventfully until birth with preservation
of renal function (19). The application of PCN by local
anesthesia may provide a significant advantage, especially
in the pregnant patient subgroup. In cases where the
nephrostomy tube needs to be replaced, general anesthesia
can be prevented in these patients and the fetus can be
protected from the potential side effects of anesthesia.
Tschada et al. evaluated the outcome of internal urinary
diversion in complicated pregnancy hydronephrosis and
found that complications were seen in 11 of 14 patients
and obstruction was relieved in only 6 patients after longterm follow-up. They concluded that internal drainage
should be well evaluated in complicated pregnancy
hydronephrosis (20). Several studies have shown that DJS
is an effective and safe method for symptomatic pregnancy
hydronephrosis treatment (6,7,21,22). However, most of
these studies are small case-group and noncomparative
studies. Conservative and surgical treatment outcomes for
pregnancy hydronephrosis have also been compared in
many studies (17,23,24). These studies have demonstrated
that DJS is an effective and safe method for the treatment
of pregnancy hydronephrosis. Percutaneous nephrostomy
has been performed in a small number of cases in a

few studies and successful results have been reported
(19,24–26). Most recently, Khoo et al. assessed the shortterm complications and success rate of percutaneous
nephrostomy during pregnancy (27). Eight patients
successfully underwent nephrostomy and sepsis occurred
in 1 patient. They pointed out acceptable technical and
clinical results of percutaneous nephrostomy during
pregnancy, but these studies were also retrospective, small
case-group, and noncomparative studies.
The predictive value of RI in pregnancy hydronephrosis
has been analyzed to give a decision about intervention.
Bodakci et al. enrolled 27 pregnant patients with unilateral
symptomatic persistent hydronephrosis (group 1) and 38
pregnant patients with physiological hydronephrosis of
pregnancy (group 2). Renal Doppler USG was performed
to detect RI and Delta RI (the difference between the RI of
the corresponding and contralateral kidney) of all pregnant
patients. The mean renal RI of the hydronephrosis side
was 0.68 ± 0.05 in group 1 and 0.60 ± 0.05 in group 2 (P
< 0.001). The mean delta RI of group 1 was significantly
higher than the mean delta RI of group 2 (0.07 ± 0.03
versus 0.02 ± 0.01, respectively, P < 0.001). They concluded
that the delta RI was more provocative than RI in order to
determine the intervention in pregnancy hydronephrosis
(28). Atar et al. also evaluated Doppler USG in the
management of symptomatic pregnancy hydronephrosis.
They found higher RI values for kidneys with ureteric
obstruction than contralateral normal kidneys and they
treated these patients with semirigid URS (29). In our
study, the RI values of both groups were higher than
0.60 (0.68 and 0.64), which was generally accepted as the
threshold value, but there was no significant difference
between the groups (P = 0.455). Hydronephrosis in
pregnancy is common in the second and third trimesters
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and usually becomes symptomatic during this time (30).
Symptoms mostly initiated and intervention was required
in our patients at the end of the second trimester and at the
beginning of the third trimester in accordance with this
knowledge. In our study, the rate of both second and third
intervention in the DJS group was higher than in the PCN
group. The time that elapsed until the second and third
interventions was longer for the patients that underwent
PCN. Although DJS and PCN are equally effective for
urgent decompression of the collecting system, we found
that this is not the case for pregnant patients. There may
be many reasons for this situation: different encrustation
rates depending on the structures of the inserted catheters,
different biochemical and hormonal characteristics of
patients, and physiological ureter dilatation. We have not
conducted an analysis of these factors and this is one of
the shortcomings of our study. We decided to question the
quality of life of the patients with the EuroQol EQ-5D form,

but we gave up because this form did not have validity for
our language. As we have already mentioned, physiological
ureter dilation is a well-known phenomenon in pregnant
women with the influence of hormonal and mechanical
factors, and we attribute the frequent dislocation of the
stents to this situation. Other shortcomings of our study
include the small number of cases and the retrospective
nature. More consistent results may be obtained with
prospective, randomized trials with more cases involving
the detailed stent and patient factors discussed above.
We concluded that PCN is more effective and feasible
than DJS in symptomatic pregnancy hydronephrosis
treatment, because patients with PCN require less reintervention and their re-intervention time is longer. On
the grounds that many factors may affect this situation,
our results need to be verified with prospective studies
including more patients and analyzing more variables.
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